Scarica l'app Stockscreener
1.25
8.76%
-0.12
Bionano Genomics Inc Azioni (BNGO) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
22.19%
8.171
|
6.687 | 7.951 | 7.367 | 6.733 |
| Cost Of Revenue |
12.29%
3.857
|
3.435 | 4.552 | 3.997 | 3.256 |
Selling, General, and Administrative
|
6.67%
8.544
|
8.01 | 8.706 | - | - |
| Costs And Expenses |
3.44%
11.53
|
11.15 | 11.94 | 11.91 | 11.28 |
| Operating Income/Loss |
8.60%
-7.218
|
-7.897 | -8.536 | -8.538 | -7.80 |
| Nonoperating Income/Loss |
50.00%
-0.198
|
-0.396 | 0.638 | 0.049 | 0.953 |
| Income/Loss From Continuing Operations Before Tax |
10.58%
-7.416
|
-8.293 | -7.898 | -8.489 | -6.847 |
| Income Tax Expense/Benefit |
30.00%
0.007
|
0.01 | 0.035 | 0.014 | 0.01 |
| Net Income/Loss |
10.60%
-7.423
|
-8.303 | -7.933 | -8.503 | -6.857 |
| Basic Average Shares |
5.16%
11.55
|
10.98 | - | 5.338 | 3.441 |
| Diluted Average Shares |
5.16%
11.55
|
10.98 | - | 5.338 | 3.441 |
| Basic Earnings Per Share |
15.79%
-0.64
|
-0.76 | - | -1.59 | -1.99 |
| Diluted Earnings Per Share |
15.79%
-0.64
|
-0.76 | - | -1.59 | -1.99 |
4.90%
7.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):